Shenzhen, China

Han Rong


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Han Rong

Introduction

Han Rong is a notable inventor based in Shenzhen, China. He has made significant strides in the field of addiction treatment through his innovative research and patent contributions. His work focuses on the use of specific microRNAs in the preparation of drugs aimed at treating psychoactive substance addiction.

Latest Patents

Han Rong holds a patent for the use of miR-132 and miR-212 in the preparation of a drug for treating addiction. This patent outlines a non-therapeutic method for regulating DAT gene expression in a cell. The method includes steps to increase or decrease the amount of miR-132/212 in the cell. Furthermore, it provides applications for these microRNAs, their enhancers, or attenuators in preparing drugs that regulate dopamine uptake by cells. This innovative approach has the potential to significantly impact the treatment of addiction.

Career Highlights

Han Rong is affiliated with Shenzhen Kangning Hospital, which is also known as the Shenzhen Mental Health Institute and Shenzhen Mental Health Center. His work at this institution has allowed him to collaborate with other professionals in the field, enhancing the impact of his research.

Collaborations

Some of Han Rong's notable coworkers include Xiaojian Jia and Mei Yang. Their collaboration has contributed to the advancement of research in mental health and addiction treatment.

Conclusion

Han Rong's innovative contributions to addiction treatment through his patent on miR-132 and miR-212 highlight the importance of research in mental health. His work at Shenzhen Kangning Hospital and collaborations with other professionals further emphasize the potential for advancements in this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…